CRSP Q2 EPS Estimate Reduced by Brookline Capital Management
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Brookline Capital Management cut their Q2 2025 earnings estimates for shares of CRISPR Therapeutics in a research report issued on Tuesday, May 6th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings of ($1.23) per share for the quarter, down […]
More Stories
Focus Partners Wealth Invests $247,000 in Five Below, Inc. (NASDAQ:FIVE)
Focus Partners Wealth bought a new position in shares of Five Below, Inc. (NASDAQ:FIVE – Free Report) during the fourth...
34,663 Shares in Viper Energy, Inc. (NASDAQ:VNOM) Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Viper Energy, Inc. (NASDAQ:VNOM – Free Report)...
Amazon.com, Inc. (NASDAQ:AMZN) Holdings Increased by BNP Paribas
BNP Paribas boosted its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 0.8% in the fourth quarter, HoldingsChannel reports. The...
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.71 Million Stake in Teladoc Health, Inc. (NYSE:TDOC)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its stake in Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 10.0% in...
Janus Henderson Group PLC Buys 134 Shares of F5, Inc. (NASDAQ:FFIV)
Janus Henderson Group PLC grew its stake in F5, Inc. (NASDAQ:FFIV – Free Report) by 2.2% in the fourth quarter,...
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Position in First BanCorp. (NYSE:FBP)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in First BanCorp. (NYSE:FBP – Free Report) by 4.0% in the...